Page last updated: 2024-12-06

tibenelast

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Tibonelast is a synthetic compound with a complex chemical structure that was developed as a potential therapeutic agent for various medical conditions. Research has focused on its potential effects on inflammation, pain, and certain types of cancer. Its unique chemical properties have made it a subject of interest in drug development, and ongoing studies are aimed at further understanding its mechanisms of action and potential therapeutic applications. The synthesis of tibenelast involves a multi-step process, and its exact mechanism of action is still being elucidated. However, preliminary studies suggest that it may exert its effects by modulating specific cellular pathways involved in inflammation and pain signaling. The potential for tibenelast to be used as a therapeutic agent is being investigated in clinical trials. However, further research is required to assess its safety, efficacy, and optimal dosage for various medical conditions.'

tibenelast: RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID59913
CHEMBL ID2111055
SCHEMBL ID449748
MeSH IDM0175931

Synonyms (22)

Synonym
benzo(b)thiophene-2-carboxylic acid, 5,6-diethoxy-
tibenelastum [latin]
tibenelast [inn]
h051v8lj93 ,
97852-72-7
tibenelastum
tibenelast
5,6-diethoxybenzo(b)thiophene-2-carboxylic acid
unii-h051v8lj93
tibenclast
nsc108930
nsc-108930
5,6-diethoxy-1-benzothiophene-2-carboxylic acid
SCHEMBL449748
PDUXMHXBBXXJFQ-UHFFFAOYSA-N
5,6-diethoxybenzothiophene-2-carboxylic acid
CHEMBL2111055
DTXSID10243289
AKOS030587206
nsc 108930
Q27279397
5,6-diethoxybenzo[b]thiophene-2-carboxylic acid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Heart rates in response to isoproterenol dosing were fitted by linear regression, and horizontal shifts in the regression lines were examined between the three treatments."( Effect of tibenelast (a phosphodiesterase inhibitor) and theophylline on isoproterenol-stimulated heart rate, cyclic AMP and norepinephrine levels.
Bowsher, RR; Cerimele, BJ; McNay, JL; Rowe, H; Schwertschlag, US, 1993
)
0.69
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]